Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pavel

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Dermatology|March 24, 2021
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week resultsBrett King, Emma Guttman-Yassky, Elena Peeva, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
No association between dupilumab use and short-term cancer development in atopic dermatitis patientsShayan Owji, Benjamin Ungar, Danielle P Dubin, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2019
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthoodTali Czarnowicki, Helen He, Talia Canter, et al.
The British Journal of Dermatology|June 3, 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomesYael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2018
An integrated model of alopecia areata biomarkers highlights both T<sub>H</sub>1 and T<sub>H</sub>2 upregulationTeresa Song, Ana B Pavel, Huei-Chi Wen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 18, 2018
Atopic dermatitis in African American patients is TRiana D Sanyal, Ana B Pavel, Jacob Glickman, et al.
Allergy|September 30, 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseasesAna B Pavel, Ester Del Duca, Julia Cheng, et al.
Archives of Dermatological Research|February 26, 2022
Secukinumab responses vary across the spectrum of congenital ichthyosis in adultsRachel Lefferdink, Stephanie M Rangel, Margot Chima, et al.
The Journal of Allergy and Clinical Immunology|July 3, 2018
Atopic dermatitis in Chinese patients shows T<sub>H</sub>2/T<sub>H</sub>17 skewing with psoriasiform featuresTom C Chan, Riana D Sanyal, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|April 23, 2019
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing diseasePatrick M Brunner, Helen He, Ana B Pavel, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Dermatology|March 24, 2021
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week resultsBrett King, Emma Guttman-Yassky, Elena Peeva, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 29, 2022
No association between dupilumab use and short-term cancer development in atopic dermatitis patientsShayan Owji, Benjamin Ungar, Danielle P Dubin, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2019
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthoodTali Czarnowicki, Helen He, Talia Canter, et al.
The British Journal of Dermatology|June 3, 2022
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomesYael Renert-Yuval, Joel Correa da Rosa, Sandra Garcet, et al.
The Journal of Allergy and Clinical Immunology|July 9, 2018
An integrated model of alopecia areata biomarkers highlights both T<sub>H</sub>1 and T<sub>H</sub>2 upregulationTeresa Song, Ana B Pavel, Huei-Chi Wen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 18, 2018
Atopic dermatitis in African American patients is TRiana D Sanyal, Ana B Pavel, Jacob Glickman, et al.
Allergy|September 30, 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseasesAna B Pavel, Ester Del Duca, Julia Cheng, et al.
Archives of Dermatological Research|February 26, 2022
Secukinumab responses vary across the spectrum of congenital ichthyosis in adultsRachel Lefferdink, Stephanie M Rangel, Margot Chima, et al.
The Journal of Allergy and Clinical Immunology|July 3, 2018
Atopic dermatitis in Chinese patients shows T<sub>H</sub>2/T<sub>H</sub>17 skewing with psoriasiform featuresTom C Chan, Riana D Sanyal, Ana B Pavel, et al.
Journal of the American Academy of Dermatology|April 23, 2019
The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing diseasePatrick M Brunner, Helen He, Ana B Pavel, et al.
Pageof 8